Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Namandjé N Bumpus

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Toxicology and Applied Pharmacology|October 1, 2011
Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytesNamandjé N Bumpus
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 25, 2012
Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolismLindsay J Yanakakis, Namandjé N Bumpus
Journal of Inorganic Biochemistry|January 26, 2010
Cross-linking of human cytochrome P450 2B6 to NADPH-cytochrome P450 reductase: Identification of a potential site of interactionNamandjé N Bumpus, Paul F Hollenberg
ACS Medicinal Chemistry Letters|October 14, 2014
Structure-Activity Studies Reveal the Oxazinone Ring Is a Determinant of Cytochrome P450 2B6 Activity Toward EfavirenzPhilip M Cox, Namandjé N Bumpus
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2011
5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independentNamandjé N Bumpus, Eric F Johnson
Chemmedchem|November 19, 2016
Single Heteroatom Substitutions in the Efavirenz Oxazinone Ring Impact Metabolism by CYP2B6Philip M Cox, Namandjé N Bumpus
Molecular Pharmacology|July 16, 2008
Investigation of the mechanisms underlying the differential effects of the K262R mutation of P450 2B6 on catalytic activityNamandjé N Bumpus, Paul F Hollenberg
Molecular Pharmacology|October 10, 2013
Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese miceLindsay B Avery, Namandjé N Bumpus
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2014
A targeted proteomics approach for profiling murine cytochrome P450 expressionElisabeth M Hersman, Namandjé N Bumpus
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 28, 2012
Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maravirocYanhui Lu, Craig W Hendrix, Namandjé N Bumpus
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Toxicology and Applied Pharmacology|October 1, 2011
Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytesNamandjé N Bumpus
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 25, 2012
Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolismLindsay J Yanakakis, Namandjé N Bumpus
Journal of Inorganic Biochemistry|January 26, 2010
Cross-linking of human cytochrome P450 2B6 to NADPH-cytochrome P450 reductase: Identification of a potential site of interactionNamandjé N Bumpus, Paul F Hollenberg
ACS Medicinal Chemistry Letters|October 14, 2014
Structure-Activity Studies Reveal the Oxazinone Ring Is a Determinant of Cytochrome P450 2B6 Activity Toward EfavirenzPhilip M Cox, Namandjé N Bumpus
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2011
5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independentNamandjé N Bumpus, Eric F Johnson
Chemmedchem|November 19, 2016
Single Heteroatom Substitutions in the Efavirenz Oxazinone Ring Impact Metabolism by CYP2B6Philip M Cox, Namandjé N Bumpus
Molecular Pharmacology|July 16, 2008
Investigation of the mechanisms underlying the differential effects of the K262R mutation of P450 2B6 on catalytic activityNamandjé N Bumpus, Paul F Hollenberg
Molecular Pharmacology|October 10, 2013
Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese miceLindsay B Avery, Namandjé N Bumpus
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2014
A targeted proteomics approach for profiling murine cytochrome P450 expressionElisabeth M Hersman, Namandjé N Bumpus
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 28, 2012
Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maravirocYanhui Lu, Craig W Hendrix, Namandjé N Bumpus
Pageof 6